Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 2
2002 1
2003 1
2005 2
2006 1
2007 3
2009 2
2010 3
2011 3
2012 2
2013 4
2014 2
2015 3
2016 3
2017 2
2018 2
2019 3
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
Németh G, Laszlovszky I, Czobor P, Szalai E, Szatmári B, Harsányi J, Barabássy Á, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW. Németh G, et al. Lancet. 2017 Mar 18;389(10074):1103-1113. doi: 10.1016/S0140-6736(17)30060-0. Epub 2017 Feb 7. Lancet. 2017. PMID: 28185672 Clinical Trial.
Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose strengths in patients with schizophrenia or schizoaffective disorder (PRISMA-1).
Llaudó J, Anta L, Ayani I, Martínez J, Schronen J, Morozova M, Ivanov M, Gutierro I. Llaudó J, et al. Int Clin Psychopharmacol. 2016 Nov;31(6):323-31. doi: 10.1097/YIC.0000000000000139. Int Clin Psychopharmacol. 2016. PMID: 27416102 Clinical Trial.
Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations.
Ma L, Xiang Q, Zhao N, Hu C, Fang M, Tan Y, Chen S, Wang Z, Liu P, Sun K, Li Y, Wu F, Tian H, Fang M, Zhao X, Wang G, Cui Y. Ma L, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110241. doi: 10.1016/j.pnpbp.2020.110241. Epub 2021 Jan 2. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33400943 Clinical Trial.
The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T, Isayama H, Nakai Y, Ito Y, Togawa O, Toda N, Arizumi T, Kogure H, Yamamoto K, Mizuno S, Yashima Y, Yagioka H, Sasaki T, Matsubara S, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K. Tsujino T, et al. J Gastroenterol. 2013 Aug;48(8):982-8. doi: 10.1007/s00535-012-0698-5. Epub 2012 Oct 24. J Gastroenterol. 2013. PMID: 23090004 Clinical Trial.
36 results